---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-094507"
form_type: "8-K"
ticker: "SNGX"
cik: "0000812796"
company_name: "SOLIGENIX, INC."
filed_at: "2025-09-29T23:59:59+00:00"
generated_at: "2026-05-17T05:30:04.026620+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Soligenix closes $7.5M public offering; cash runway extended through 2026

## Summary
- Gross proceeds of ~$7.5M from sale of 5,555,560 units at $1.35/unit, each consisting of one share (or pre-funded warrant) and one warrant.
- Warrants exercisable at $1.35 per share for five years from issuance; 1,162,064 existing warrants amended to same terms.
- Cash runway now extends through end of 2026 to fund key clinical/commercial inflection points.
- Net proceeds to fund R&D, commercialization, working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001104659-25-094507
- form_type: 8-K
- ticker: SNGX
- cik: 0000812796
- company_name: SOLIGENIX, INC.
- filed_at: 2025-09-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/812796/000110465925094507/0001104659-25-094507-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/812796/000110465925094507/sngx-20250925x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-094507
- JSON: https://secwatch.observer/filing/0001104659-25-094507.json
- Plain text: https://secwatch.observer/filing/0001104659-25-094507.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.